GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandion Oncology A/S (OSTO:SCOL) » Definitions » Float Percentage Of Total Shares Outstanding

Scandion Oncology A/S (OSTO:SCOL) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Scandion Oncology A/S Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Scandion Oncology A/S's float shares is 0.00 Mil. Scandion Oncology A/S's total shares outstanding is 134.25 Mil. Scandion Oncology A/S's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Scandion Oncology A/S's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Scandion Oncology A/S's Institutional Ownership is 0.01%.

Scandion Oncology A/S Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Scandion Oncology A/S's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/134.25
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scandion Oncology A/S (OSTO:SCOL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandion Oncology A/S (OSTO:SCOL) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSTO:EXPRS2 OSTO:COMBI XSAT:ABERA OSTO:LPGO NGM:COEGIN XSAT:CHOSA OSTO:2CUREX OSTO:BIOSGN XSAT:APTA XSAT:DBP B OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
8VY:Germany
Address
Fruebjergvej 3, Symbion, Copenhagen, DNK, 2100
Website
https://www.scandiononcology.com
Scandion Oncology A/S is a clinical-stage biotechnology company developing first-in-class medicines aimed at treating cancer that is resistant to current treatment options. Cancer Drug Resistance Company discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options.

Scandion Oncology A/S (OSTO:SCOL) Headlines

No Headlines